Skip to content

The Diabetes Patient Takes Responsibility

DiaTast - Patient Reported Experience in a New Out-patient Structure With Patient-initiated Visits

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03083899
Acronym
DiaTast
Enrollment
357
Registered
2017-03-20
Start date
2017-03-01
Completion date
2019-12-22
Last updated
2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 1, Health Care Economics and Organizations, Patient Reported Outcome

Keywords

Diabetes, Organization, Out-patient control

Brief summary

People with Type 1 diabetes (T1D) are randomized to follow the normal scheduled visit procedure in the outpatient clinic OR to have open access to the clinic, i.e. they can get an appointment with a nurse or doctor within defined time intervals via telephone, e-mail or apps. Patient-reported outcomes (patient satisfaction and experience, QoL) clinical variables (HbA1c, blood pressure etc.) and use of human resources (doctors, diabetes-nurses and diet physicians) are monitored.

Detailed description

This is a 24 month prospective randomized controlled trial. People with Type 1 diabetes (T1D) are randomized to two groups: (i) Patients randomized to the control group receive their standard diabetes care and are seen in the out-patient clinic with regular intervals (typically a diabetes nurse every 3-4 month and a diabetes doctor once a year. (ii) Patients randomized to the intervention group are not called for at fixed time points. They can arrange visits in the diabetes clinic whenever they feel the need to do so. The have a guarantee for a consultation with a diabetes nurse within one week and with a diabetes doctor or diet physician within two weeks. Questionnaires (a specific questionnaire focused on patient satisfaction developed for the study and AddQoL) are filled in at time 0 and 24 month. Blood samples for diabetes-related variables (HbA1c, lipid status), blood pressure, body weight etc. are likewise recorded at time 0 and 24 month. Economic and time requirements are evaluated at 24 month.

Interventions

OTHEROut-patient clinic on demand (patient-initiated)

Free use of any resources in the out-patient clinic

OTHERScheduled out-patient clinic

Scheduled use of the out-patient clinic

Sponsors

Esbjerg Hospital - University Hospital of Southern Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Type 1 diabetes 18 - 80 years Multiple injections or Insulin pump therapy

Exclusion criteria

Newly diagnosed T1D Psychiatric illness Need for translation Unstable conditions such as progressive retinopathy

Design outcomes

Primary

MeasureTime frameDescription
Patient reported outcome24 monthQuestionnaire regarding satisfaction of the out-patient clinic

Secondary

MeasureTime frameDescription
Clinical diabetes variables 124 monthHbA1c
Health Care Economy24 monthUse of resources in the out-patient clinic
Clinical diabetes variables 224 monthBlood pressure
Clinical diabetes variables 324 monthLipids
Diabetes Dependent quality of Life24 monthQuestionnaire

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026